DYNAMIC EFFICIENCY AND PRICING OF PHARMACEUTICAL INNOVATIONS | American Journal of Health Economics: Vol 0, No ja

New paper by @basucally.bsky.social! How much of a drug's social value should go to innovators? 100% maximizes long-run welfare, but less if society prioritizes consumer surplus—especially when small countries can free-ride on others' R&D. #DrugPricing www.journals.uchicago.edu/doi/10.1086/...

Trump Threatens 100% Tariffs on Drugmakers Over Pricing — Democracy Observer article

Trump's tariff threat on drugmakers could reshape healthcare access and affordability, impacting the balance between corporate interests a...

More at democracy.observer/posts/trump-threatens-10...

#DemocracyObserver #DrugPricing #Accountability

Trump Threatens 100% Tariffs on Drugmakers Over Pricing

Trump's tariff threat on drugmakers could reshape healthcare access and impact the balance of power between government and industry,...

📖 democracy.observer/posts/trump-threatens-10...

#DemocracyObserver #DrugPricing #AccountabilityInHealthcare

Admin touts TrumpRX success: it’s a quick fix, not real progress! via The Hill News — A new analysis from The New York Times, along with German outlets NDR and WDR, took a closer look at the administration’s new drug pricing platform, TrumpRx. What they found is that while some prices have come down, Americans are still paying significantly more than patients in other wealthy countries,

Analysis shows TrumpRX has lowered some drug prices, but Americans still pay significantly more than those in other wealthy nations.

resist47.news — news & tools for the resistance.

#resist47 #TrumpRx
#DrugPricing
#HealthcareCosts
#Pharmaceuticals

Mark Cuban says Trump Rx saving people ‘a lot of money’ on some drugs via The Hill News — Billionaire enterpreneur Mark Cuban on Wednesday touted the federal government’s TrumpRx drug platform, saying the initiative is saving Americans money. “Everyone wants me to rip on TrumpRx,” Cuban wrote on the social platform X. “Reality is, it’s saving patients money on IVF and a few other drugs. A lot of money. IMO, anything that saves…

Mark Cuban says the TrumpRx drug platform is saving patients "a lot of money" on some medications, including IVF drugs.

More stories at resist47.news

#resist47 #TrumpRx
#DrugPricing
#MarkCuban
#HealthcareSavings

Hey folks! Did you know drug prices are going through the roof? It's wild! Imagine if we had vending machines for meds,easy access for everyone! Let's chat about how we can make this happen. We deserve better! Join the convo!

#HealthAccess #DrugPricing #MedVendingMachines

Granted drug price concessions hit 'concerning' high The number of granted medicine price concessions reached a three-year high in February, Community Pharmacy England has revealed.

Granted drug price concessions hit 'concerning' high

buff.ly/hjBOdBV

#medicines #drugs #drugpricing #drugprices #pharmacy #UKpharmacy

Granted drug price concessions hit 'concerning' high The number of granted medicine price concessions reached a three-year high in February, Community Pharmacy England has revealed.

Granted drug price concessions hit 'concerning' high

buff.ly/ilGHuC3

#medicines #drugs #drugpricing #drugprices #pharmacy #UKpharmacy

The MFN Terminology Maze. What pharmaceutical leaders need to know about Most Favored Nation pricing in 2026. Lumanity logo.

Cutting through the MFN confusion. Voluntary agreements, TrumpRx, CMMI models all called “MFN,” all fundamentally different.

Our new article clarifies each MFN pathway and the implications for your strategy.

Read it here: lumanity.com/perspectives...

#MarketAccess #DrugPricing #MFN

House passes bill to change contract‑pharmacy rules, reporting and limits on 340B revenues after heated debate Engrossed Second Substitute Senate Bill 59 81, which revises state law governing 340B contract pharmacies, reporting, and how covered entities may use program revenues, passed after extensive amendment debate on transparency, profit‑use limits, charity‑care thresholds and legal risk; vote was 67‑30.

The House has just passed a controversial bill aimed at reshaping the 340B drug pricing program, igniting fierce debate over its potential risks and benefits for rural hospitals!

Read the full story

#WA #CitizenPortal #HealthCarePolicy #RuralHospitals #DrugPricing

Drug price concessions hit three-year high The number of drug price concessions hit a three-year high in February 2026, in what Community Pharmacy England (CPE) has called a “concerning escalation”. Price concessions are granted for generic…

The number of drug price concessions hit a three-year high in February 2026, in what #CPE has called a “concerning escalation”

#drugpricing #healthandcarepolicy #ukhealthcare #NHS

buff.ly/Vu6wMqA

ファイザー、TrumpRxでコスト削減プログラム開始 30超の医薬品で割引を提示 | STELLANEWS.LIFE STELLANEWS.LIFE（ステラニュース・ライフ）は、科学や技術、医薬品分野における最新の研究成果や発見 | STELLANEWS.LIFE（ステラニュース・ライフ）は、科学や技術、医薬品分野における最新の研究成果や発見

Pfizer Launches Cost-Savings Program on TrumpRx, Offering Discounts on Over 30 Medicines

stellanews.life/technology/8...

#Pfizer #TrumpRx #HealthcareCosts #DrugPricing #GoodRx #PatientAccess

@moreperfectunion.bsky.social | More Perfect Union: "What the Maker of Ozempic Doesn't Want You to Know: It's Bankrupting America" | #PharmaceuticalDrugs #NovoNordisk #Wegovy #GLP1 #Medicare #DrugPricing #PriceGouging #Patent #LegalMonopoly #ProfitsOverPatients
www.youtube.com/watch?v=JqHm...

Member of Congress, a physician, says high drug costs are forcing patients to skip medications An unidentified member of Congress who identified themself as a physician and military veteran said patients are skipping doses, splitting pills or going without medicines because they cannot afford alternatives; the speaker called the drug-pricing debate "overly simplistic."

A member of Congress revealed that patients are risking their health by skipping medications due to skyrocketing drug costs, calling the current debate on pricing "overly simplistic."

Read the full story

#US #UnitedStatesHealthcare #PatientSupport #HealthcareAccess #CitizenPortal #DrugPricing

Trump says he threatened 100 per cent tariff on French wine over drug prices - Yes Punjab News Trump threatens 100% tariff on French wine to push global drug pricing reforms, highlighting his aggressive trade strategy and US-Europe tensions.

Trump says he threatened 100 per cent tariff on French wine over drug prices yespunjab.com?p=219251

#Trump #Tariffs #France #Macron #DrugPricing #USPolitics #TradeWar #GlobalTrade #HealthcareCosts #Economy #WineTariffs #USvsEurope #BigPharma #Policy #Geopolitics

TrumpRx launches to lower US drug prices, but early reaction is mixed | Becaris Publishing

TrumpRx launches to lower US drug prices, but early reaction is mixed | Becaris Publishing becarispublishing.com/digital-cont... #DrugPricing #MFN #MostFavoredNation #MarketAccess

Fears US drug pricing deal will weigh heavy on the NHS The UK confirms that the cost of the drug pricing deal with the US, initially around £1bn over three years, will be borne by the health department

The UK confirms that the cost of the #drugpricing deal with the US, initially around £1bn over three years, will be borne by the health department. #pharmanews #healthnews #lifesciences #healthpolicy pharmaphorum.com/news/fears-u...

CMS to enter negotiations with drugmakers over the price of four cancer medications - The Cancer Letter The Center for Medicare and Medicaid Services is entering negotiations with drugmakers over the price of 15 medications this year. The newly announced list includes four drugs used to treat cancer. To...

CMS enters negotiations with drugmakers that include four high-cost cancer medications in the latest price negotiation program, aiming for more affordable treatment. #DrugPricing #HealthPolicy #TCSC
cancerletter.com/cancer-polic...

Trump Administration Applauds Itself for Rx Access Agreements, But Will They Help Patients?
adapadvocacyassociation.blogspot.com/2026/01/trump-administra... #MFN #DrugPricing #PatientAccess

Trump Administration Applauds Itself for Rx Access Agreements, But Will They Help Patients? By:  Marcus J. Hopkins , Health Policy Lead Consultant, ADAP Advocacy In May 2025, President Donald J. Trump signed an executive order requi...

Trump Administration Applauds Itself for Rx Access Agreements, But Will They Help Patients?
adapadvocacyassociation.blogspot.com/2026/01/trump-administra... #MFN #DrugPricing #PatientAccess

In case you missed our latest blog, "Trump Administration Applauds Itself for Rx Access Agreements, But Will They Help Patients?"
adapadvocacyassociation.blogspot.com/2026/01/trump-administra... #MFN #DrugPricing #PatientAccess

Trump Administration Applauds Itself for Rx Access Agreements, But Will They Help Patients?
adapadvocacyassociation.blogspot.com/2026/01/trump-administra... #MFN #DrugPricing #PatientAccess

Read our latest blog, "Trump Administration Applauds Itself for Rx Access Agreements, But Will They Help Patients?"
adapadvocacyassociation.blogspot.com/2026/01/trump-administra... #MFN #DrugPricing #PatientAccess

Trump Administration Pushes Two New Rebate Models, But Will They Help Patients?
adapadvocacyassociation.blogspot.com/2026/01/trump-administra... #GUARD #GLOBE #Rebates #DrugPricing

Trump Administration Pushes Two New Rebate Models, But Will They Help Patients?
adapadvocacyassociation.blogspot.com/2026/01/trump-administra... #GUARD #GLOBE #Rebates #DrugPricing

US pharma MFN and tariff dynamics: What EU and UK leaders need to know Europe and the United Kingdom are entering a period of direct exposure to US policy choices, and the implications are significant and immediate.

#MostFavouredNationpricing #MFNpricing #MFNpolicy #USpharma #Drugpricing #MFN #Tariffs #accessframeworks #brandedmedicines #MFNframework #MFNthresholds #MFNcalculations #generics #APIs #pharmasupplychains #tariffadvantagedpathways #USUKEconomicProsperityDeal #MFNagreements
zurl.co/OcqZ6

Drug pricing reform is back in the spotlight. 

Global pricing, direct-to-consumer meds, unclear enforcement...

Big promises, big questions. 

What actually changes and who really benefits from this? 

#HealthcareReform #DrugPricing #BigPharma #HealthEconomy #FutureOfHealthcare

In case you missed our latest blog, "Trump Administration Pushes Two New Rebate Models, But Will They Help Patients?"
adapadvocacyassociation.blogspot.com/2026/01/trump-administra... #GUARD #GLOBE #Rebates #DrugPricing

Trump Administration Pushes Two New Rebate Models, But Will They Help Patients?
adapadvocacyassociation.blogspot.com/2026/01/trump-administra... #GUARD #GLOBE #Rebates #DrugPricing

Read our latest blog, "Trump Administration Pushes Two New Rebate Models, But Will They Help Patients?"
adapadvocacyassociation.blogspot.com/2026/01/trump-administra... #GUARD #GLOBE #Rebates #DrugPricing